Search

Changes to Formulary as of 14th June 2018:

BNF Category Number

Product/indication

Detail of change

4.8.1

Brivaracetam

Added as GREEN PLUS drug

1.2.1

Glycopryonnium (Sinalar) oral solution

Added as GREEN PLUS drug

5.1.2

Ceftazidime / Avibactam

Added as RED drug

5.1.2

Ceftobiprole

Added as RED drug

6.1.1.1

Humalog Insulin KwikPen Junior

New pen device added with 0.5 units

3.11

Pirfenidone

Added link to NICE TA 504

8.1.5

Ixazomib

Added as a RED drug and added link to NICE TA505

10.1.4

Lesinurad

Added as NOT APPROVED and added link to NICE TA506

5.3.3.2

Sofosbuvir-Velpatasvir-Voxilaprevir

Added as a RED drug and added link to NICE TA507

10.1.5

Autologous chondrocyte implantation

Added as a RED drug and added link to NICE TA508

10.1.4

Pertuzumab

Added as a RED drug and added link to NICE TA509

10.1.4

Daratumumab

Added as a RED drug and added link to NICE TA510

13.5.3

Brodalumab

Added as a RED drug and added link to NICE TA511

10.1.4

Tivozanib

Added as a RED drug and added link to NICE TA512

10.1.4

Obinutuzumab

Added as a RED drug and added link to NICE TA513

8.1.5

Regorafenib

Added as a RED drug and added link to NICE TA514

8.1.5

Eribulin

Added as NOT APPROVED and added link to NICE TA515

8.1.5

Cabozantinib

Added as a RED drug and added link to NICE TA516

7.4.5

PDE5 inhibitors

Added statement from NTAG regarding daily vs on demand use of PDE-5 inhibitors

1.3

Sucralfate

Remove from formulary

6.1.1

Insulins

High strength insulins added

3.2.3

Trimbow

Added to formulary as GREEN

3.2.3

Trelegy

Added to formulary as GREEN

4.4

Methylphenidate

Added all brand of MR methyphenidate as per shared care guidance

2.8.1

Enoxaparin Becat (Biosimilar)

Added to formulary as GREEN

10.1.3 and 8.2.1

Mycophenolate mofetil, mycophenolic acid: updated contraception advice for male patients

Added link to MHRA DSU Guidance

8.2.4

Daclizumab (Zinbryta▼): suspension and recall for safety reasons; review patients as soon as possible and start alternative therapy

Changed status to NOT APPROVED and added link to MHRA DSU Guidance

13.10.4

Head lice eradication products: risk of serious burns if treated hair is exposed to open flames or other sources of ignition, eg, cigarettes

Added link to MHRA DSU Guidance

8

N/A

Added link to NG85

4.4

N/A

Added link to NG86

6

N/A

Added link to NG88 and removed link to CG44

2

N/A

Added link to NG89

4

N/A

Added link to NG92